Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2011. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain financial performance data.
Material Changes
The filing discloses a specific transaction involving Mr. J R Stéphenne, a Person Discharging Managerial Responsibility:
- Transaction Type: Sale of Ordinary shares.
- Quantity: 50,000 shares.
- Price: 1,377.148 pence per share.
- Date of Transaction: July 27, 2011.
- Notification Date: July 28, 2011.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory notification of a director's share sale.
Key Facts for Investor Verification
- Verify the total shareholding of Mr. J R Stéphenne following the sale of 50,000 shares.
- Confirm the market price of GSK shares on July 27, 2011, to assess the transaction price relative to the market.
- Check for any other concurrent insider trading activity during the same period.